GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 98 filers reported holding GENERATION BIO CO in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,910,071 | -63.0% | 1,249,382 | -50.0% | 0.03% | -60.3% |
| Q3 2022 | $13,275,000 | -30.2% | 2,500,000 | -13.7% | 0.07% | -29.8% |
| Q2 2022 | $19,006,000 | -26.0% | 2,897,300 | -17.2% | 0.10% | -16.1% |
| Q1 2022 | $25,690,000 | +3.7% | 3,500,000 | 0.0% | 0.12% | 0.0% |
| Q4 2021 | $24,780,000 | -71.8% | 3,500,000 | 0.0% | 0.12% | -69.8% |
| Q3 2021 | $87,745,000 | -6.8% | 3,500,000 | 0.0% | 0.41% | +6.8% |
| Q2 2021 | $94,150,000 | +1.2% | 3,500,000 | +7.0% | 0.38% | -17.1% |
| Q1 2021 | $93,078,000 | +44.7% | 3,270,500 | +44.1% | 0.46% | +19.6% |
| Q4 2020 | $64,321,000 | -1.9% | 2,268,819 | +7.0% | 0.39% | -14.6% |
| Q3 2020 | $65,549,000 | +47.3% | 2,120,625 | +0.1% | 0.45% | +27.2% |
| Q2 2020 | $44,495,000 | – | 2,118,819 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
| GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
| HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
| Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
| PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
| Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
| Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
| BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |